stockrow
Friday 6 November 2026
Export MDLN’s income statement to Excel — free account
Medline Inc.
MDLN Healthcare Medical Instruments & Supplies
Medline Inc.’s revenue for fiscal 2025 (year ended December 2025) was $28.4 billion, up 11.5% from fiscal 2024.
- Revenue
- +14.1%
- Free cash flow
- +916.1%
- Total debt
- −23.7%
Quarter to September 2026, against a year earlier
39.96
0.39
−0.97%
Follow MDLN
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 From the 10-Q filed 4 Nov | |
|---|---|---|---|---|---|
|
+4 more TTM periods Free account |
— | 0.00% | 0.00% | 3.18% | |
| 0.00% | 2.58% | 3.58% | 1.49% | ||
ROIC |
0.00% | 19.84% | 19.94% | 17.80% | |
Return on Tangible Assets |
0.00% | 7.21% | 5.13% | 3.97% | |
Average Days of Receivables |
0.00 | 46.78 | 44.98 | 45.14 | |
Free Cash Flow per Share |
4.18 | 2.79 | 2.69 | 3.54 | |
Free Cash Flow |
3,383.00 | 2,284.00 | 2,304.00 | 3,101.00 | |
Capital Expenditures |
(1,009.00) | (751.00) | (764.00) | (795.00) | |
| Other line items | |||||
Cash ROIC |
10.01% | 6.69% | 6.71% | 9.70% | |
Accounts Receivable Turnover |
— | 0.00 | 0.00 | 8.75 | |
Accounts Payable Turnover |
— | — | 0.00 | 21.07 | |
Inventory Turnover |
— | — | 0.00 | 4.73 | |
Average Days of Payables |
0.00 | 0.00 | 18.32 | 20.16 | |
Days of Inventory on Hand |
0.00 | 0.00 | 81.93 | 80.13 | |
Tax Rate |
— | 0.00 | (0.02) | (0.03) | |
Research and Development Expense of Revenue |
— | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
— | 0.00% | 15.71% | 15.82% | |
Share Based Compensation of Revenue |
— | 0.00% | 0.29% | 0.31% | |
Interest Coverage |
— | — | 13.44 | 15.28 | |
Operating CF/Net income |
0.00 | 3.14 | 4.36 | 6.88 | |
Depreciation/Fixed assets |
0.56 | 0.39 | 0.40 | 0.00 | |
Capex/Depreciation |
(0.38) | (0.40) | (0.41) | 0.00 | |
Revenue per Share |
0.00 | 35.00 | 34.67 | 35.00 | |
Operating CF per Share |
5.42 | 3.71 | 3.58 | 4.45 | |
Capex per Share |
(1.25) | (0.92) | (0.89) | (0.91) | |
Capex to Sales |
0.00 | 0.03 | 0.03 | 0.03 |
Columns are period end dates · fundamentals updated 4 Nov 2026